SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 36 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,130,000 | -25.2% | 5,296,501 | 0.0% | 0.00% | – |
| Q1 2022 | $1,511,000 | +5.8% | 5,296,501 | +0.9% | 0.00% | – |
| Q4 2021 | $1,428,000 | +54.4% | 5,248,399 | +160.5% | 0.00% | – |
| Q3 2021 | $925,000 | -23.7% | 2,014,798 | 0.0% | 0.00% | – |
| Q2 2021 | $1,213,000 | -11.7% | 2,014,798 | 0.0% | 0.00% | – |
| Q1 2021 | $1,374,000 | +9714.3% | 2,014,798 | +5436.1% | 0.00% | – |
| Q4 2020 | $14,000 | -76.3% | 36,394 | -70.5% | 0.00% | – |
| Q3 2020 | $59,000 | +555.6% | 123,394 | +580.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 18,146 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -33.3% | 18,146 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +12.5% | 18,146 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | -20.0% | 18,146 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | -74.4% | 18,146 | -68.3% | 0.00% | – |
| Q1 2019 | $39,000 | +69.6% | 57,232 | +39.7% | 0.00% | – |
| Q4 2018 | $23,000 | -93.5% | 40,981 | -69.7% | 0.00% | – |
| Q3 2018 | $352,000 | – | 135,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 331,543 | $90,000 | 0.01% |
| Sterneck Capital Management, LLC | 25,000 | $7,000 | 0.00% |
| Landmark Financial Advisors, LLC | 24,200 | $7,000 | 0.00% |
| MSD Partners, L.P. | 349,290 | $96,000 | 0.00% |
| Jacobi Capital Management LLC | 18,500 | $5,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 74,300 | $20,000 | 0.00% |
| Focused Wealth Management, Inc | 500 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 307 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 810 | $0 | 0.00% |
| NORTHERN TRUST CORP | 245,399 | $67,000 | 0.00% |